Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.87052 | 37 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.78929 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.79269 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.71519 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.71665 | 34 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.91956 | 37 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.86892 | 36 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.77101 | 34 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.74135 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.76846 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.7821 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.74845 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.80148 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78723 | 35 |